BioSpace News Archive

Policy

Trump Hints White House Could Attempt to Overrule New FDA Vaccine Guidance

If that guidance comes to pass, it would delay potential EUA of a vaccine until the end of 2020 or early 2021 – well after the Nov. 3 election.

September 24, 2020
·
3 min read
·
Alex Keown
FDA

FDA Grants Mereo’s Setrusumab Rare Pediatric Disease Designation

Under that designation, Mereo may qualify for a voucher that can be used for a priority review of a subsequent marketing application for a different product than Setrusumab.

September 24, 2020
·
2 min read
·
Mark Terry
Job Trends

Sanofi’s Toujeo Improves Diabetes Control, Giving Patients More Time in Range

For diabetic patients, achieving a certain “time in range” is a more realistic glucose control strategy than striving for a particular daily target, according to researchers working with Sanofi who spoke during the 56th Annual Meeting of the European Association for the Study of Diabetes.

September 24, 2020
·
5 min read
·
Gail Dutton
Career Advice

The Right Way to Show Enthusiasm in an Interview Follow up Email

While it’s only a few hundred words, writing a good follow-up email accomplishes a few important things. Here’s how you can write an impressive interview follow up email.

September 24, 2020
·
2 min read
·
Laura Brothers
Business

BioSpace Movers & Shakers, Sept. 25

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.

September 24, 2020
·
6 min read
·
Alex Keown
Deals

Taysha Makes Rapid Ascent from Launch to IPO

Starting with $30 million in seed financing in April, Taysha sprinted through a $95 million Series B in August and rounded the corner this Thursday to bring in $157 million for its IPO.

September 24, 2020
·
2 min read
·
Kate Goodwin
Drug Development

What Next-Generation COVID-19 Antibody Therapeutics Need to Succeed

First-generation therapeutics have been largely ineffective against the SARS-CoV-2 virus, resulting in significant challenges and opportunities for the second-generation therapeutics that are being designed now.

September 24, 2020
·
4 min read
·
Gail Dutton
BioForest

Lumen Bioscience Receives $4 Million Grant to Develop COVID-19 GI Therapies

Lumen Bioscience was awarded a $4 million grant by the U.S. Army Medical Research and Development Command to develop a rapid, scalable and inexpensive biologic drug cocktail to treat gastrointestinal infection in COVID-19 patients.

September 24, 2020
·
3 min read
·
Mark Terry
Genetown

Research Roundup: Two Types of Parkinson’s Disease and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

September 24, 2020
·
5 min read
·
Mark Terry
Drug Development

Study: SARS-CoV-2 Infection During Pregnancy Does Not Increase Risk of Complications

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy does not appear to increase the risk of complications during delivery or negatively impact the health of newborns, according to a new JAMA study.

September 24, 2020
·
2 min read
·
Brandon May